A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Kineta Inc.
Namida Lab
Imperial College London
Hamilton Health Sciences Corporation
Charite University, Berlin, Germany
SpeciCare
KU Leuven
Threshold Pharmaceuticals
National Cancer Institute (NCI)